- Home
- FGEN vs SURG Comparison
FGEN vs SURG Comparison
Compare FGEN & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- SURG
- Stock Information
- Founded
- FGEN 1993
- SURG 2006
- Country
- FGEN United States
- SURG United States
- Employees
- FGEN N/A
- SURG N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- SURG Advertising
- Sector
- FGEN Health Care
- SURG Consumer Discretionary
- Exchange
- FGEN Nasdaq
- SURG Nasdaq
- Market Cap
- FGEN 33.5M
- SURG 56.5M
- IPO Year
- FGEN 2014
- SURG N/A
- Fundamental
- Price
- FGEN $5.37
- SURG $3.30
- Analyst Decision
- FGEN Strong Buy
- SURG Strong Buy
- Analyst Count
- FGEN 1
- SURG 1
- Target Price
- FGEN $250.00
- SURG $9.00
- AVG Volume (30 Days)
- FGEN 60.6K
- SURG 103.6K
- Earning Date
- FGEN 08-05-2025
- SURG 08-12-2025
- Dividend Yield
- FGEN N/A
- SURG N/A
- EPS Growth
- FGEN N/A
- SURG N/A
- EPS
- FGEN N/A
- SURG N/A
- Revenue
- FGEN $6,996,000.00
- SURG $40,029,467.00
- Revenue This Year
- FGEN N/A
- SURG $57.76
- Revenue Next Year
- FGEN N/A
- SURG $112.61
- P/E Ratio
- FGEN N/A
- SURG N/A
- Revenue Growth
- FGEN N/A
- SURG N/A
- 52 Week Low
- FGEN $4.50
- SURG $1.05
- 52 Week High
- FGEN $38.25
- SURG $3.47
- Technical
- Relative Strength Index (RSI)
- FGEN 36.45
- SURG 63.03
- Support Level
- FGEN $4.85
- SURG $2.86
- Resistance Level
- FGEN $5.73
- SURG $3.34
- Average True Range (ATR)
- FGEN 0.51
- SURG 0.25
- MACD
- FGEN -0.00
- SURG 0.04
- Stochastic Oscillator
- FGEN 24.19
- SURG 87.80
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.